Coute Ryan A, Nathanson Brian H, Shekhar Aditya C, White Christopher N, Kurz Michael C, Jackson Elizabeth A, Mader Timothy J
Department of Emergency Medicine, University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama.
OptiStatim, LLC, Longmeadow, Massachusetts.
Prehosp Emerg Care. 2024 Mar 27:1-7. doi: 10.1080/10903127.2024.2327526.
To calculate disability-adjusted life years (DALY) and labor productivity loss due to drug overdose out-of-hospital cardiac arrest (DO-OHCA) and compare its contribution to the burden of disease and economic impact of all-cause nontraumatic out-of-hospital cardiac arrest (OHCA) in the US.
We performed a retrospective observational cohort analysis of all adult (age 18 years) nontraumatic emergency medical services-treated OHCA events, including those due to DO-OHCA, from the national Cardiac Arrest Registry to Enhance Survival (CARES) database from January 1, 2017 and December 31, 2020. The main outcome measures of interest were disability-adjusted life years, annual, and lifetime labor productivity loss over the 4-year study period. The findings for the study population were extrapolated to a national level using the CARES population catchment and U.S. population estimates by year.
A total of 378,088 adult OHCA events, including 23,252 DO-OHCA (6.2%) met study inclusion criteria. The DO-OHCA DALY increased from 156,707 in 2017 to 265,692 in 2020. Per year, DO-OHCA contributed to 11.4%, 12.0%, 10.5%, and 11.4% of all OHCA DALY lost from 2017-2020, respectively. The mean annual and lifetime productivity losses for all OHCA were stable over time (annual: $47K in 2017 to $50K in 2020; lifetime: $647K in 2017 to $692K in 2020). The CARES population catchment increased by 39.8% over the study period (102.6 M in 2017 to 143.4 M in 2020). For DO-OHCA, the mean annual productivity loss was approximately 30% higher than non-DO-OHCA ($64K vs. $49K in 2020, respectively). The mean lifetime productivity loss for DO-OHCA was 2.5 times higher than non-DO-OHCA ($1.6 M vs. $630K in 2020, respectively).
The DALY due to DO-OHCA has increased over time with expansion of the CARES dataset, but its relative contribution to total OHCA DALY (all non-traumatic etiologies) remained fairly stable. The DO-OHCAs represent approximately 6% of all adult non-traumatic EMS-treated OHCA events but has a disproportionately greater economic impact. Continued efforts to reduce DO-OHCA through public health initiatives are warranted to lessen the societal impact of OHCA in the U.S.
计算因院外心脏骤停(OHCA)药物过量导致的伤残调整生命年(DALY)和劳动生产率损失,并比较其对美国所有非创伤性院外心脏骤停(OHCA)疾病负担和经济影响的贡献。
我们对2017年1月1日至2020年12月31日期间全国心脏骤停登记以提高生存率(CARES)数据库中所有接受非创伤性紧急医疗服务治疗的成人(18岁及以上)OHCA事件进行了回顾性观察队列分析,包括因药物过量导致的院外心脏骤停(DO-OHCA)事件。主要关注的结局指标是伤残调整生命年、4年研究期间的年度和终身劳动生产率损失。使用CARES人口覆盖范围和美国各年份的人口估计数,将研究人群的结果推算至全国水平。
共有378,088例成人OHCA事件,包括23,252例DO-OHCA(6.2%)符合研究纳入标准。DO-OHCA的DALY从2017年的156,707增加到2020年的265,692。每年,DO-OHCA分别占2017 - 2020年所有OHCA损失DALY的11.4%、12.0%、10.5%和11.4%。所有OHCA的年均和终身生产率损失随时间保持稳定(年均:2017年为4.7万美元,2020年为5.0万美元;终身:2017年为64.7万美元,2020年为69.2万美元)。在研究期间,CARES人口覆盖范围增加了39.8%(2017年为1.026亿,2020年为1.434亿)。对于DO-OHCA,年均生产率损失比非DO-OHCA高约30%(2020年分别为6.4万美元和4.9万美元)。DO-OHCA的平均终身生产率损失是非DO-OHCA的2.5倍(2020年分别为160万美元和63万美元)。
随着CARES数据集的扩大,DO-OHCA导致的DALY随时间增加,但其对总OHCA DALY(所有非创伤性病因)的相对贡献保持相当稳定。DO-OHCA约占所有接受非创伤性紧急医疗服务治疗的成人OHCA事件的6%,但其经济影响却大得多。有必要通过公共卫生举措继续努力减少DO-OHCA,以减轻OHCA对美国社会的影响。